Pfizer Inc.

NYSE:PFE   3:59:58 PM EDT
43.10
-1.02 (-2.31%)
5:12:43 PM EDT: $43.03 -0.07 (-0.16%)
Products

FDA Grants Breakthrough Therapy Designation To Pfizer’S Group B Streptococcus Vaccine Candidate To Help Prevent Infection In Infants Via Immunization Of Pregnant Women

Published: 09/07/2022 11:48 GMT
Pfizer Inc. (PFE) - FDA Grants Breakthrough Therapy Designation to Pfizer’s Group B Streptococcus Vaccine Candidate to Help Prevent Infection in Infants Via Immunization of Pregnant Women.
Pfizer Inc - Study Remains Ongoing, and Pfizer Will Publish Outcomes From This Clinical Trial When It is Completed.